Checklist · Corporate

Board Governance, Minutes, and Corporate Formalities: A Practical Checklist

26 U.S.C. § 409

Type
Checklist
Jurisdiction
National
Date
2024-02-12
Topic
Corporate

Corporate governance is the unglamorous work that decides whether a company survives its own success. This checklist walks a private company through the governance calendar, the mechanics of valid board and stockholder meetings, action by unanimous written consent, and the discipline of minutes that record decisions without creating discoverable landmines. It covers the board resolutions that make equity grants and 409A valuations defensible, the disclosure-and-recusal process that cleanses conflicted transactions under Delaware General Corporation Law § 144, committee charters, the D&O insurance and indemnification package, and the formalities that preserve limited liability against a veil-piercing claim. It closes with books-and-records demands under DGCL § 220 and the diligence test every minute book eventually faces: whether an acquirer's counsel can trace every share, option, and material decision to a valid authorization. Corporate law is state law, and Delaware is the reference point throughout — confirm your own state of incorporation's rules before acting.

Board Governance, Minutes, and Corporate Formalities: A Practical Checklist

Corporate > Corporate Governance | Published 12 February 2024 - Updated 18 August 2025 | UpLaw - uplaw.us

No one has ever been thanked for keeping good minutes. But at the closing table, in a derivative suit, or across the table from an IRS examiner, the minute book is the only witness that cannot be impeached. Build it while nothing is going wrong.

Keywords: board of directors, corporate minutes, corporate formalities, DGCL 141, written consent, quorum and notice, annual meeting, 409A valuation, option grants, conflicted transactions, indemnification, D&O insurance, veil piercing, books and records, minute book

A note on which law governs. Corporate governance is state law. A corporation's internal affairs — how directors are elected, what a quorum is, when a conflicted deal is cleansed — are governed by the law of the state of incorporation, not the state where the company operates. This checklist uses the Delaware General Corporation Law (DGCL) as its reference point, because most venture-backed and many closely held companies incorporate there and because Delaware's case law is the most developed. A large group of states has adopted some version of the Model Business Corporation Act (MBCA), whose rules are similar in structure but differ in detail (the MBCA's conflicting-interest-transaction provisions in §§ 8.60–8.63, for example, are drafted quite differently from DGCL § 144). Nothing in this checklist states a nationwide rule of corporate governance, because there is no such thing. Federal law is the exception: the tax rules — 26 U.S.C. § 409A on deferred compensation, § 422 on incentive stock options — and the federal securities exemptions apply everywhere. Read every "Delaware" reference below as "Delaware, and check your own state of incorporation."

Meet Tidewater Analytics

Tidewater Analytics, Inc. is a Delaware C-corporation, four years old, twenty-two employees, one seed round and one Series A behind it. Its two founders are competent engineers and indifferent record-keepers. The board is five people: two founders, two investor directors, one independent. Tidewater has never held an annual stockholder meeting. Its option grants live in a spreadsheet. Its 409A valuations exist, but nobody can find the board consent approving the last two. When Cardinal Systems signs a letter of intent to acquire Tidewater for $58 million, Cardinal's counsel opens the data room, asks for the minute book, and the deal very nearly dies. We will follow Tidewater through every phase.

Phase 1 — The governance calendar: annual meeting, board meetings, and the record

  • [ ] Identify the state of incorporation and pull the current certificate of incorporation (with all amendments) and bylaws. Everything below is subject to them.
  • [ ] Read the bylaws for: number of directors, notice periods, quorum, meeting mechanics, officer roles, and the fiscal year.
  • [ ] Confirm whether a voting agreement or investors' rights agreement dictates board composition (common director, preferred directors, independent director) and who has the right to designate each seat.
  • [ ] Build a 12-month governance calendar: annual stockholder meeting, four to six regular board meetings, 409A refresh dates, audit/tax deadlines, franchise tax and annual report filings, D&O policy renewal.
  • [ ] Designate a Secretary (or corporate-governance owner) with actual responsibility for the minute book, the stock ledger, and the consent file.
  • [ ] Create or reconstitute the minute book: charter and amendments, bylaws, all board and stockholder minutes and consents, stock ledger, option ledger, equity plan and amendments, indemnification agreements, D&O policies.

Why it matters, and the traps. DGCL § 211(b) requires an annual meeting of stockholders for the election of directors; § 211(c) lets the Court of Chancery order one on application by any stockholder or director if none has been held for thirteen months. Private companies skip the annual meeting constantly, and it is usually harmless — until it is not, because directors whose terms have expired are holdover directors, and an opposing stockholder can weaponize that. The deeper trap is that governance is a habit, not an event. A company that meets four times a year with an agenda, materials, and minutes produces a defensible record almost automatically. A company that governs by text message produces nothing, and then tries to reconstruct three years of history in the two weeks before a closing. Tidewater is the second kind. For the structural decisions that precede all of this, see Incorporating a Startup the Right Way: A Founder's Legal Checklist and The Startup Legal Document Stack: What Founders Need and Why.

Phase 2 — Notice, quorum, and the mechanics of a valid meeting

  • [ ] Give notice of each board meeting exactly as the bylaws require (medium, recipients, and days of advance notice). Calendar invites are not automatically notice.
  • [ ] Circulate an agenda and board materials in advance — ideally 48–72 hours — so directors can actually read them.
  • [ ] Confirm a quorum before acting. Under DGCL § 141(b) the default is a majority of the total number of directors; the bylaws may set a different number but not fewer than one-third.
  • [ ] Confirm the vote required: the default is a majority of directors present at a meeting at which a quorum is present.
  • [ ] For remote participation, rely on DGCL § 141(i): directors may participate by conference telephone or other means by which all participants can hear each other, and participation constitutes presence.
  • [ ] Obtain written waivers of notice (DGCL § 229) where notice was short or defective, or note attendance without objection.
  • [ ] For stockholder meetings: set a record date (DGCL § 213), give notice not less than 10 nor more than 60 days before the meeting (DGCL § 222), and prepare the stockholder list (DGCL § 219).
  • [ ] Track quorum loss mid-meeting if directors drop off — and note it in the minutes rather than pretending it did not happen.

Why it matters, and the traps. An action taken at an invalidly noticed meeting without a quorum is voidable, and in a fight over control it will be attacked. Two traps recur. First, companies treat the investor directors' calendars as the notice requirement and forget the independent director; a director who is deliberately not told about a meeting has a powerful equitable claim, and Delaware courts are hostile to board action taken behind a director's back. Second, boards "meet" on a group chat and then paper it later. That is not a meeting — but it can still be a valid unanimous written consent if it is documented properly, which is Phase 3.

Phase 3 — Action by unanimous written consent: when it works and when it does not

  • [ ] Confirm the charter does not prohibit board action by written consent (DGCL § 141(f) permits it unless the charter or bylaws provide otherwise).
  • [ ] Obtain the signature of every director then in office. Board written consent must be unanimous — there is no majority-consent shortcut, and an abstaining director must still sign.
  • [ ] Use written consent for routine, uncontroversial, time-sensitive items: option grants, officer appointments, bank resolutions, ratifications.
  • [ ] Do not use written consent to paper over a decision that required deliberation — a major transaction, a related-party deal, a valuation with real judgment in it.
  • [ ] Date the consent accurately and record the effective date. Do not backdate. Ever.
  • [ ] For stockholder written consent, check DGCL § 228: unless the charter says otherwise, stockholders may act by consent of the holders of the minimum number of votes needed to approve at a meeting — i.e., a majority in most cases, not unanimity — but § 228(e) requires prompt notice to non-consenting stockholders.
  • [ ] File the executed consent in the minute book immediately, with all signature pages, and reference it in the next meeting's minutes.

Why it matters, and the traps. The unanimity requirement for board consents (§ 141(f)) versus the majority rule for stockholder consents (§ 228) is the single most commonly confused pair of rules in startup governance. A "unanimous written consent of the board" signed by four of five directors approves nothing. Tidewater has three such consents in its file, including the one purporting to adopt its 2022 stock plan amendment. The other trap is backdating. A consent dated to make an option grant look earlier — and cheaper — is not a paperwork convenience; it is potentially securities fraud, tax fraud under § 409A, and an accounting restatement. Delaware provides a lawful cure for defective corporate acts: the ratification procedures of DGCL §§ 204 and 205. Use them. Do not use a pen.

Phase 4 — Minutes: what to record, what NOT to record, and who drafts them

  • [ ] Assign one drafter (Secretary or counsel) and one reviewer. Draft minutes within one week, while memory is fresh.
  • [ ] Record: date, time, place/means; who attended and who was absent; who else was present (counsel, CFO, guests) and when they left; confirmation of quorum; the materials distributed; each resolution adopted, verbatim; the vote; abstentions and recusals; adjournment.
  • [ ] Record that the board received and considered the relevant materials, and identify them by name ("the Board reviewed the Independent Valuation Report dated March 3, 2025, prepared by Anchorage Valuation Partners").
  • [ ] Do not transcribe debate. Do not attribute doubts to named directors. Do not write "Director Okoye expressed concern that the projections were unrealistic."
  • [ ] Do not speculate about legal exposure in minutes. Route legal analysis through counsel in a privileged memo and note only that "the Board received advice of counsel regarding X."
  • [ ] Note when the board goes into executive session and when counsel is present for privileged advice — but keep the substance out.
  • [ ] Circulate the draft to directors and counsel, then approve the minutes at the next meeting and record the approval.
  • [ ] Keep the final signed minutes, the board materials, and the resolutions as one indexed package.

Why it matters, and the traps. Minutes are simultaneously the company's shield and, if written carelessly, the plaintiff's best exhibit. They are the primary evidence that the board was informed — the duty that Smith v. Van Gorkom, 488 A.2d 858 (Del. 1985), made famous by holding a board grossly negligent for approving a merger after a two-hour meeting on an oral presentation with no valuation materials. They are also the primary evidence of board-level oversight under In re Caremark International Inc. Derivative Litigation, 698 A.2d 959 (Del. Ch. 1996), and its successors — Stone v. Ritter, 911 A.2d 362 (Del. 2006), which folded Caremark into the duty of loyalty, and Marchand v. Barnhill, 212 A.3d 805 (Del. 2019), which sustained a Caremark claim precisely because the board minutes showed no monitoring of the company's central compliance risk (food safety, at an ice cream company). Minutes that show a board that received reports and asked for follow-up defeat a Caremark claim at the pleading stage. Minutes that show nothing do not.

The mirror-image trap is over-writing. Minutes are discoverable and are among the first documents produced in a derivative suit or a books-and-records action. The goal is a record that proves process without narrating anxiety. Write what the board decided and what it considered; not what it worried about. If a preservation obligation attaches, that changes the calculus entirely — see Issuing a Litigation Hold and Preserving ESI: A Practical Checklist. The doctrinal foundations here are developed at length in Corporate Governance and Fiduciary Duties: A Comprehensive Guide for Directors and Officers.

Phase 5 — Approving equity: option grants, 409A valuations, and the board resolution

  • [ ] Confirm the equity incentive plan was validly adopted by the board and approved by stockholders (stockholder approval is required for incentive stock options under 26 U.S.C. § 422(b)(1), within 12 months before or after board adoption).
  • [ ] Confirm the share reserve has capacity for the grant. Count outstanding grants, not just issued shares.
  • [ ] Obtain a current 409A valuation — an independent appraisal, refreshed at least every 12 months and after any material event (a priced round, a term sheet, a major contract, an acquisition approach).
  • [ ] Have the board expressly accept the valuation and set the exercise price at or above the resulting fair market value, in a resolution that names the appraiser and the report date.
  • [ ] Approve each grant with the complete terms: grantee, number of shares, exercise price, grant date, vesting commencement date, vesting schedule, ISO or NSO, and post-termination exercise period.
  • [ ] Have the grantee countersign the option agreement and the plan documents; keep them.
  • [ ] Confirm the securities exemption for the grant — for private companies, typically Rule 701 (17 C.F.R. § 230.701) — and track the Rule 701 volume caps and disclosure thresholds.
  • [ ] Update the capitalization table and option ledger the same week, and reconcile the ledger to the minute book quarterly.
  • [ ] Under DGCL § 152 and § 157, confirm the board (not an officer acting alone) authorized the issuance and determined the consideration.

Why it matters, and the traps. Section 409A of the Internal Revenue Code treats a stock option granted with an exercise price below fair market value as deferred compensation, with brutal consequences for the employee: immediate income inclusion on vesting, a 20% additional federal tax, and premium interest. The regulations give private companies a safe harbor: a valuation by an independent appraiser, not more than 12 months old, is presumed reasonable, and the IRS bears the burden of showing it was grossly unreasonable. That presumption is only available if the board actually used the valuation — which means there must be a board resolution, dated on or after the report, setting the exercise price by reference to it.

Tidewater's problem is exactly here. Its January grants were made at a $1.10 strike; the only 409A report in the file is dated four months later and shows $1.62. There is no consent adopting either. Cardinal's counsel now has a potential § 409A exposure across forty employees, and Cardinal's response is predictable: a special indemnity and a seven-figure escrow holdback. The fix costs Tidewater real money at closing. On the founder side of the same problem, see Founder Equity, Vesting, and the 83(b) Election: A Practical Checklist.

Phase 6 — Conflicted transactions: disclosure, recusal, and the cleansing vote

  • [ ] Circulate an annual director and officer questionnaire capturing outside boards, competing investments, family relationships, and interests in vendors or customers.
  • [ ] Adopt a written related-party transaction policy with a defined threshold and an approval path.
  • [ ] Before any interested transaction, have the interested director make full disclosure of all material facts — the interest itself and the facts about the transaction.
  • [ ] Have the interested director leave the room for deliberation and vote, and record the recusal in the minutes.
  • [ ] Approve by the affirmative vote of a majority of the disinterested directors, even if that is less than a quorum — a route DGCL § 144 has long expressly permitted.
  • [ ] Alternatively (or additionally) obtain disinterested stockholder approval after full disclosure — the second cleansing route under § 144.
  • [ ] Independently document that the transaction is fair to the corporation. Fairness is the third route under § 144 and, in any event, entire fairness remains the judicial backstop.
  • [ ] Confirm the current text of DGCL § 144 before relying on any of the three routes. Delaware substantially rewrote § 144 in 2025, and the subsection numbering, the definition of a "disinterested" director, and the treatment of controlling-stockholder transactions all moved. Do not work from a memorized subsection cite.
  • [ ] For a controlling stockholder transaction, consider the MFW structure: condition the deal at the outset on both (i) approval by a well-functioning special committee of independent directors with real bargaining power and (ii) an informed, uncoerced majority-of-the-minority vote.
  • [ ] Keep the special committee's own minutes, and let it hire its own financial and legal advisors.

Why it matters, and the traps. DGCL § 144 does not make a conflicted transaction good; it removes voidability solely because of the conflict and, more importantly in practice, shifts the standard of review. Without cleansing, an interested transaction is reviewed for entire fairness — fair dealing and fair price, with the burden on the defendant fiduciary (Weinberger v. UOP, Inc., 457 A.2d 701 (Del. 1983)). With a properly constituted, fully informed, disinterested approval, the business judgment rule (Aronson v. Lewis, 473 A.2d 805 (Del. 1984)) can be restored. For controller transactions, Kahn v. M & F Worldwide Corp., 88 A.3d 635 (Del. 2014), holds that both protective devices, adopted ab initio, restore business judgment review. Two cautions. First, this is Delaware's framework; an MBCA state runs the same problem through §§ 8.60–8.63, which define "director's conflicting interest transaction" and "qualified director" in their own terms and reach some different results. Second, Delaware amended § 144 substantially in 2025 — the disclosure-and-disinterested-approval architecture above survives, but the statutory details of what counts as a cleansing vote have moved, so read the current text rather than a summary of it.

The trap is half-measures. A director who "discloses" the conflict but stays in the room, answers questions, and votes has cleansed nothing — he has simply created a record of his own participation. Recusal must be real, and the minutes must show it. The duty of loyalty behind all of this traces to Guth v. Loft, Inc., 5 A.2d 503 (Del. 1939), and it binds officers as well as directors (Gantler v. Stephens, 965 A.2d 695 (Del. 2009)).

What the minutes should actually say. When Tidewater's board finally approves a services agreement with a vendor half-owned by its CFO's brother-in-law, the minute entry that does the work is short and structural:

The Chair noted that Director Reyes had disclosed a material interest in Kestrel Data Services, LLC, described in the written disclosure memorandum distributed to the Board on April 2, 2025, which the Board reviewed. Director Reyes answered the Board's questions regarding the disclosed interest and the proposed terms and then withdrew from the meeting at 10:22 a.m. and did not participate in the deliberation or the vote. The Board reviewed the three competing vendor bids attached as Exhibit B and the CFO's comparative pricing analysis. Upon motion duly made and seconded, the disinterested directors (Okoye, Barrantes, and Lund) unanimously adopted the following resolutions... Director Reyes rejoined the meeting at 10:51 a.m.

That entry proves disclosure, proves recusal, proves an informed comparison, and identifies exactly who voted. It does not narrate anyone's misgivings. That is the whole craft.

Phase 7 — Committees: audit, compensation, and their charters

  • [ ] Confirm the board's power to create committees (DGCL § 141(c)(2)) and do it by board resolution.
  • [ ] Adopt a written charter for each committee: purpose, composition, independence requirements, authority (recommend vs. decide), meeting cadence, reporting obligation to the full board.
  • [ ] Know the limits: a committee cannot approve or adopt any action that the DGCL expressly requires stockholder approval for, and cannot adopt, amend, or repeal bylaws.
  • [ ] Compensation committee: delegate authority to approve equity grants below a stated threshold and to set officer compensation; document the delegation precisely.
  • [ ] Audit committee: oversee the auditor, the financial statements, internal controls, the whistleblower channel, and related-party transactions.
  • [ ] Have each committee keep its own minutes and report to the full board at the next regular meeting.
  • [ ] Refresh committee membership when the board changes — a committee with a resigned member is a governance defect.

Why it matters, and the traps. Committees are how a five-person board does work it could not otherwise do, and how a conflicted board insulates a decision. But delegation only works to the extent it was actually made. A "compensation committee" that exists in a term sheet but was never constituted by resolution has no authority, and every grant it "approved" is unauthorized. Committee minutes are also where the Caremark record lives for regulated companies: Marchand teaches that a board with no committee, no reporting line, and no minutes on its central risk has an oversight problem it cannot argue away.

Phase 8 — Director onboarding, information rights, and the duty to be informed

  • [ ] Give every new director an onboarding package: charter, bylaws, the financing documents, the voting agreement, the cap table, D&O policy, indemnification agreement, and the last year of minutes.
  • [ ] Deliver a monthly or quarterly reporting package (financials, cash and runway, KPIs, hiring, litigation, compliance) — and have the board acknowledge receipt in the minutes.
  • [ ] Distinguish the director's information rights (broad, as a fiduciary) from an investor's contractual information rights (defined in the investors' rights agreement).
  • [ ] Adopt a policy on the observer seat: observers attend, they do not vote, and they can be excluded from privileged or conflicted sessions.
  • [ ] Establish a confidentiality expectation for board materials, and be explicit about what a designated director may share with the fund that appointed her.
  • [ ] Escalate material events to the board between meetings; do not save bad news for the quarterly.

Why it matters, and the traps. The duty of care is a duty of process, and a board can only be informed by material actually put in front of it. Van Gorkom is the standing warning: what killed the directors there was not a bad price, it was the absence of any record that they had informed themselves. The startup trap is a founder-CEO who curates the board's information — reporting only what looks good, disclosing the customer loss two quarters late. That is a duty-of-candor problem for the CEO and a duty-of-care problem for the directors who never asked. It is also the fastest way to lose the board's support at the exact moment the company needs it. If you are adding investor directors for the first time, Bringing On New Investors After the Seed Round: Navigating the First Priced Financing explains what changes.

Phase 9 — D&O insurance, indemnification agreements, and exculpation

  • [ ] Include a § 102(b)(7) exculpation provision in the certificate of incorporation eliminating director monetary liability for duty-of-care breaches (it cannot cover loyalty breaches, bad faith, improper personal benefit, or unlawful dividends under § 174). Delaware's 2022 amendment permits officer exculpation as well, on narrower terms.
  • [ ] Add mandatory indemnification to the bylaws to the fullest extent permitted by DGCL § 145.
  • [ ] Sign an individual indemnification agreement with every director and officer — a contract cannot be amended away by a later, hostile board the way bylaws can.
  • [ ] Ensure the indemnification agreement contains advancement of expenses (DGCL § 145(e)), with an undertaking to repay if indemnification is ultimately unavailable. Advancement is the provision that actually matters when litigation starts.
  • [ ] Bind a D&O policy (DGCL § 145(g) authorizes insurance even where indemnification would not be available). Confirm Side A (individual, non-indemnifiable), Side B (company reimbursement), and Side C (entity securities claims) coverage.
  • [ ] Review exclusions with care: insured-vs-insured, prior acts, conduct exclusions, and the M&A/change-of-control provisions.
  • [ ] Buy tail ("run-off") coverage at any sale — typically six years — and negotiate who pays for it in the merger agreement.
  • [ ] Circulate the policy to the directors. A director who does not know the policy exists cannot notice a claim under it.

Why it matters, and the traps. The three-layer protection stack — exculpation (charter), indemnification (bylaws plus contract), insurance (policy) — has to be built before the claim, because none of it can be created retroactively. The classic trap is a company that has a fine indemnification bylaw and no advancement right, so a director facing a derivative suit funds her own defense for two years and hopes for reimbursement. The second trap is the change-of-control blind spot: the D&O policy typically converts to run-off at closing, and if nobody bought the tail, the outgoing directors are bare for the claims that surface post-closing — which is precisely when they surface. Confirm the tail in the merger agreement itself; see Mergers and Acquisitions: A Comprehensive Guide from Letter of Intent to Closing.

Phase 10 — Corporate formalities and preserving limited liability (avoiding veil-piercing)

  • [ ] Maintain separate bank accounts for every entity. No exceptions, no "temporary" commingling.
  • [ ] Pay personal expenses from personal accounts. If the company advances something, document it as a loan with a note, a rate, and a repayment schedule.
  • [ ] Keep the corporation adequately capitalized for its foreseeable obligations — thin capitalization is a recurring veil-piercing factor.
  • [ ] Sign contracts in the corporate name and representative capacity: "Tidewater Analytics, Inc., By: /s/ ___, Name: ___, Title: CEO." Never sign a corporate contract in a bare personal name.
  • [ ] Use the full legal entity name (with "Inc." or "LLC") on contracts, invoices, purchase orders, the website, and email signatures.
  • [ ] Observe the formalities the entity's own governing documents require: meetings, consents, officer elections, annual reports, franchise tax.
  • [ ] For multi-entity structures (holdco/opco, subsidiaries), keep separate boards, separate books, separate minute books, and arm's-length intercompany agreements with real consideration.
  • [ ] Do not let a parent's officers make an operating subsidiary's day-to-day decisions without the subsidiary's own board acting.
  • [ ] Keep the stock ledger current and accurate; it is the corporation's official record of ownership.

Why it matters, and the traps. Veil-piercing is state law and the factors vary — but the recurring themes are consistent nationwide: commingling of funds, failure to observe formalities, undercapitalization, use of the entity as a mere instrumentality or alter ego, and (in most formulations) resulting fraud or injustice. Delaware requires a showing of both an alter-ego relationship and an element of fraud or injustice, and its courts are famously reluctant to pierce; New York's classic articulation runs through Walkovszky v. Carlton, 18 N.Y.2d 414 (1966); the Seventh Circuit's Sea-Land Services, Inc. v. Pepper Source, 941 F.2d 519 (7th Cir. 1991), is the canonical illustration of the unity-of-interest plus injustice test. Applying Delaware law, Fletcher v. Atex, Inc., 68 F.3d 1451 (2d Cir. 1995), declined to pierce where a parent and subsidiary used a cash-management system but maintained genuine separateness. And the Supreme Court's United States v. Bestfoods, 524 U.S. 51 (1998), confirms the baseline: a parent is not liable for a subsidiary's acts merely by virtue of ownership; liability requires either piercing or the parent's own direct participation.

The practical lesson is boring and decisive: separateness is a habit. If you run more than one entity, read Running Multiple Businesses Under One Structure: A Deep Dive into Holding, Operating, and Parent Companies, and make sure the entity you chose is the one you are actually operating — Choosing a Tax Entity: A Practical Checklist covers the front end of that decision. Contracts signed in the wrong name are a first cousin of the same problem; The Commercial Contracts Toolkit: Drafting, Reviewing, and Enforcing Business Agreements covers signature blocks and authority.

Phase 11 — Books-and-records demands and stockholder information rights

  • [ ] Know the statute: DGCL § 220 gives a stockholder of record (or beneficial owner) the right to inspect the corporation's books and records upon a written demand under oath stating a proper purpose.
  • [ ] Understand what "proper purpose" means: a purpose reasonably related to the person's interest as a stockholder — investigating suspected mismanagement, valuing shares, communicating with other stockholders.
  • [ ] On receipt of a demand, calendar the five-business-day response window in § 220(c) and route it immediately to counsel. Do not have the CEO answer it by email.
  • [ ] Verify the technical requisites: stockholder status, the oath, the stated purpose, the documents sought, and any agent's power of attorney. Technical defects are a legitimate basis to push back — briefly.
  • [ ] Negotiate scope: the statutory right is to records "necessary and essential" to the stated purpose, not to unrestricted discovery. Board minutes and consents are the core; emails and informal materials are available only when formal records are shown to be inadequate.
  • [ ] Insist on a confidentiality agreement as a condition of production, and on incorporation-by-reference into any later complaint.
  • [ ] Recognize the strategic reality: § 220 is the pre-suit tool plaintiffs use to plead demand futility, and Delaware courts have repeatedly told stockholders to use it — see the "tools at hand" line of authority following Rales/Aronson and books-and-records decisions such as Saito v. McKesson HBOC, Inc., 806 A.2d 113 (Del. 2002), and Seinfeld v. Verizon Communications, Inc., 909 A.2d 117 (Del. 2006) (demand must show a credible basis to infer wrongdoing).
  • [ ] Keep the records inspection-ready at all times. A clean minute book is the best possible response to a § 220 demand; a chaotic one invites the inference the demand is designed to prove.

Why it matters, and the traps. A § 220 demand is not a nuisance letter — it is usually the first move in a derivative suit, and Delaware has made clear that stockholders who sue without using § 220 first will be met with skepticism. The trap is stonewalling. A company that refuses a facially proper demand loses the summary proceeding, pays some of the demander's costs, and hands the plaintiff a narrative of concealment. The other trap is the opposite: producing everything, including the very board emails and internal analyses the company would rather not have in the complaint, because nobody negotiated scope. Also note that most states have an analogous inspection right — MBCA § 16.02 is the common template — and LLCs have their own regime under the LLC statute and operating agreement.

Phase 12 — The diligence test: would your minute book survive an acquirer's review?

  • [ ] Trace every share ever issued from board authorization → stock purchase agreement → stock ledger entry → certificate or book entry. No orphans.
  • [ ] Trace every option ever granted from plan → share reserve capacity → board consent → 409A support → signed option agreement → ledger entry.
  • [ ] Confirm every charter amendment was approved by the board and by stockholders, and was actually filed with the Secretary of State.
  • [ ] Confirm every board written consent is unanimous and fully signed, with all signature pages present.
  • [ ] Confirm officer appointments and that the people signing contracts held the titles they signed under.
  • [ ] Confirm each material contract, debt, lease, and IP assignment was authorized to the extent the bylaws or financing documents require board or preferred-stockholder consent.
  • [ ] Reconcile the cap table to the minute book, share by share. They must agree exactly.
  • [ ] Run a defect inventory and cure it: DGCL § 204 (ratification of defective corporate acts by the board, with stockholder approval where required) and DGCL § 205 (Court of Chancery validation) exist precisely for this.
  • [ ] Assemble a governance section of the data room before the LOI, not after.

Why it matters, and the traps. Governance defects do not kill deals; they reprice them. Cardinal Systems does not walk away from Tidewater. It does three things: it extends the exclusivity period by six weeks while Tidewater's counsel runs a § 204 ratification, it demands a special indemnity for the § 409A exposure with a $2.4 million escrow carve-out, and it converts what was a no-shop into a hard leverage position on price. Tidewater's founders spend the summer reconstructing four years of consents, chasing signature pages from a director who left the board in 2023, and paying two law firms to do work that would have taken the Secretary four hours a quarter. That is the real cost of governance neglect: not liability, but leverage — surrendered at the exact moment the founders had the most to lose.

Get ahead of it. Getting Diligence-Ready Before You Raise: A Comprehensive Guide for Founders is the pre-financing version of this exercise; Conducting Merger and Acquisition Due Diligence: A Practical Checklist shows you what the buyer's team will actually do to you; and The Mergers and Acquisitions Toolkit maps the whole transaction.

Common Mistakes to Avoid

  1. Backdating anything. A consent, an option grant, a resolution. There is a lawful cure (DGCL §§ 204–205); backdating is not it, and it converts a paperwork problem into a fraud problem.
  2. Treating a "unanimous" written consent as a majority vote. Board consents under § 141(f) require every director's signature. Stockholder consents under § 228 do not. Confusing the two invalidates the action.
  3. Skipping the annual meeting for years. DGCL § 211(c) lets any stockholder or director get a court-ordered meeting after thirteen months. It is trivial to fix and embarrassing to explain.
  4. Granting options without a current, board-adopted 409A valuation. This is the single most common and most expensive private-company governance defect. It creates employee tax liability and buyer escrow.
  5. Letting the interested director stay in the room. Disclosure without recusal cleanses nothing under DGCL § 144, and the minutes will prove it.
  6. Minutes that narrate the debate. Never write what a director feared. Write what the board considered and what it decided.
  7. Minutes that record nothing. The mirror error. "The Board discussed various matters" is worse than useless — under Caremark and Marchand, silence in the minutes is the plaintiff's exhibit.
  8. Indemnification without advancement. The right to be reimbursed years later is not the right to have your defense paid now.
  9. No D&O tail at closing. Post-closing claims land on directors who no longer have a policy.
  10. Commingling funds or signing personally. The two fastest routes to a veil-piercing claim, and both are free to avoid.
  11. A cap table that does not tie to the minute book. If they disagree, the minute book governs — and one of your stockholders owns something different from what they think.
  12. Governing by group chat. Decisions made in a thread with no notice, no quorum, and no record are decisions no one can prove were ever made.

The Consolidated Governance Checklist

Annually

  • [ ] Hold the annual stockholder meeting; elect directors (DGCL § 211).
  • [ ] Refresh the 409A valuation.
  • [ ] Circulate D&O questionnaires; update the conflicts register.
  • [ ] Renew D&O insurance; confirm limits and exclusions.
  • [ ] File the annual report and pay franchise tax in the state of incorporation and every qualified state.
  • [ ] Reconcile cap table to stock ledger to minute book.
  • [ ] Refresh committee memberships and charters.

Every board meeting

  • [ ] Notice per the bylaws; agenda and materials circulated in advance.
  • [ ] Quorum confirmed and recorded (DGCL § 141(b)).
  • [ ] Financials, cash/runway, and risk/compliance report delivered and noted.
  • [ ] Prior minutes approved.
  • [ ] Resolutions recorded verbatim; votes, abstentions, and recusals noted.
  • [ ] Minutes drafted within one week; filed in the minute book.

Every equity grant

  • [ ] Plan capacity confirmed; 409A current and adopted by resolution.
  • [ ] Board consent (unanimous, fully signed) with all grant terms.
  • [ ] Option agreement countersigned; Rule 701 tracked; ledger updated.

Every conflicted transaction

  • [ ] Full disclosure of all material facts; interest recorded.
  • [ ] Recusal from deliberation and vote, recorded in the minutes.
  • [ ] Majority of disinterested directors (and/or disinterested stockholders) approve (DGCL § 144).
  • [ ] Fairness independently documented; special committee with its own advisors where a controller is involved.

Always

  • [ ] Separate bank accounts; no commingling; entity name on every signature block.
  • [ ] Indemnification agreements + advancement in place for every director and officer.
  • [ ] Charter § 102(b)(7) exculpation in place.
  • [ ] Minute book complete, indexed, and inspection-ready.

Primary Authority

Delaware General Corporation Law (the reference statute; confirm your own state of incorporation)

  • DGCL § 141 — Board of directors; § 141(b) quorum and voting; § 141(c) committees; § 141(f) action by unanimous written consent; § 141(i) remote participation.
  • DGCL § 144 — Interested director and officer transactions; disclosure and disinterested approval (substantially amended in 2025 — read the current text).
  • DGCL § 145 — Indemnification and advancement of expenses; § 145(e) advancement; § 145(g) insurance.
  • DGCL § 102(b)(7) — Exculpation of directors (and, since the 2022 amendments, certain officers) for duty-of-care breaches.
  • DGCL § 211 — Annual meeting of stockholders; § 211(c) court-ordered meeting after 13 months.
  • DGCL § 213 — Record date; § 219 — stockholder list; § 222 — notice of meetings; § 229 — waiver of notice.
  • DGCL § 220 — Stockholder inspection of books and records; proper purpose.
  • DGCL § 228 — Stockholder action by written consent; § 228(e) notice to non-consenting stockholders.
  • DGCL §§ 152, 157 — Board authorization of stock issuances and rights/options.
  • DGCL §§ 204, 205 — Ratification and judicial validation of defective corporate acts.

Delaware case law

Federal tax and securities

  • 26 U.S.C. § 409A — nonqualified deferred compensation; discounted options; Treas. Reg. § 1.409A-1(b)(5)(iv) (stock-right exemption and the independent-appraisal presumption of reasonable valuation).
  • 26 U.S.C. § 422 — incentive stock options, including the stockholder-approval requirement for the plan; 26 U.S.C. § 83 — property transferred for services.
  • 17 C.F.R. § 230.701 (Rule 701) — exemption for compensatory equity issuances by non-reporting companies.

Veil-piercing / alter ego (state law — factors vary by jurisdiction)

Secondary sources

  • Model Business Corporation Act §§ 8.30–8.31 (director standards of conduct and liability), §§ 8.60–8.63 (directors' conflicting-interest transactions), § 16.02 (inspection of records) — the template for most non-Delaware states.
  • Restatement (Third) of Agency §§ 2.01–2.03 (actual and apparent authority) — for who may bind the corporation.

Related UpLaw Resources

Related Guides & Articles

Related Checklists

Related Toolkits

This checklist is general legal information from UpLaw (uplaw.us), not legal advice, and does not create an attorney-client relationship. Corporate law is state law and changes over time — including significant recent amendments to the Delaware General Corporation Law — and federal tax rules under § 409A carry severe penalties for error. Verify current requirements in your state of incorporation and consult qualified counsel before acting.